[4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone

C25H32N6O2S — CID 50825840

IUPAC[4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone
SMILESCc1ccc(-c2nc3sc(N4CCN(C(=O)C5CCCO5)CC4)nn3c2NC2CCCC2)cc1
InChIInChI=1S/C25H32N6O2S/c1-17-8-10-18(11-9-17)21-22(26-19-5-2-3-6-19)31-24(27-21)34-25(28-31)30-14-12-29(13-15-30)23(32)20-7-4-16-33-20/h8-11,19-20,26H,2-7,12-16H2,1H3
InChIKeyJQIFCEIYIBNUOL-UHFFFAOYSA-N
MW480.64 g/mol
LogP3.95
Rot. Bonds5

About [4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone

[4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone (PubChem CID 50825840) has the molecular formula C25H32N6O2S and a molecular weight of 480.64 g/mol. Its IUPAC name is [4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone.

Molecular Properties

Compound Name[4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone
PubChem CID50825840
Molecular FormulaC25H32N6O2S
Molecular Weight480.64 g/mol
Exact Mass480.23
IUPAC Name[4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone
SMILESCc1ccc(-c2nc3sc(N4CCN(C(=O)C5CCCO5)CC4)nn3c2NC2CCCC2)cc1
InChIInChI=1S/C25H32N6O2S/c1-17-8-10-18(11-9-17)21-22(26-19-5-2-3-6-19)31-24(27-21)34-25(28-31)30-14-12-29(13-15-30)23(32)20-7-4-16-33-20/h8-11,19-20,26H,2-7,12-16H2,1H3
InChIKeyJQIFCEIYIBNUOL-UHFFFAOYSA-N
XLogP3.95
TPSA75.00 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500480.64
LogP ≤ 53.95
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze [4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone?
The IUPAC name of [4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone (CID 50825840) is [4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone.
What is the SMILES notation for [4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone?
The canonical SMILES for [4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone is Cc1ccc(-c2nc3sc(N4CCN(C(=O)C5CCCO5)CC4)nn3c2NC2CCCC2)cc1.
What is the InChIKey of [4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone?
The InChIKey is JQIFCEIYIBNUOL-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H32N6O2S/c1-17-8-10-18(11-9-17)21-22(26-19-5-2-3-6-19)31-24(27-21)34-25(28-31)30-14-12-29(13-15-30)23(32)20-7-4-16-33-20/h8-11,19-20,26H,2-7,12-16H2,1H3.
What are the key properties of [4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone?
[4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone has a molecular weight of 480.64 g/mol, XLogP of 3.95, 5 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[5-(cyclopentylamino)-6-(4-methylphenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperazin-1-yl]-(oxolan-2-yl)methanone is sourced from PubChem (CID 50825840), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).